Horizon Pharma plc Business Finance Contracts & Agreements

92 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Release and Waiver of Claims Agreement between Barry Moze and Horizon Therapeutics PLC
Release Agreements
Horizon Pharma plc
Pharmaceuticals
2022
Release and Waiver of Claims and Non-Competition Agreement between Brian Beeler and Horizon Therapeutics PLC
Release Agreements
Horizon Pharma plc
Pharmaceuticals
2022
Horizon Therapeutics Amended and Restated 2018 Equity Incentive Plan (as of July 29, 2021)
Equity Distribution Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2022
Horizon Therapeutics Amended and Restated 2020 Equity Incentive Plan
Equity Distribution Agreements
Horizon Pharma plc
Pharmaceuticals
IL
2022
Horizon Therapeutics plc 2014 Non-Employee Equity Plan
Equity Distribution Agreements
Horizon Pharma plc
Pharmaceuticals
CA
2021
Horizon Therapeutics Amended and Restated 2020 Equity Incentive Plan
Equity Distribution Agreements
Horizon Pharma plc
Pharmaceuticals
IL
2021
Third Supplemental Indenture to 5.500% Senior Notes Due 2027—Viela Bio, Inc., Horizon Therapeutics USA, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2021
Incremental Amendment and Lender Joinder Agreement among Horizon Therapeutics USA, Inc., JPMorgan Chase Bank, N.A., and Citibank, N.A.
Credit Agreements
Horizon Pharma plc
Pharmaceuticals
2020
Horizon Therapeutics plc Underwriting Agreement for 11,800,000 Ordinary Shares with Citigroup, Morgan Stanley, J.P. Morgan, Piper Sandler, and Stifel (August 6, 2020)
Underwriting Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2020
Horizon Therapeutics plc 2020 Equity Incentive Plan
Equity Distribution Agreements
Horizon Pharma plc
Pharmaceuticals
IL
2020
Second Supplemental Indenture to 5.500% Senior Notes Due 2027—Horizon Properties Holding LLC, Curzion Pharmaceuticals, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2020
First Supplemental Indenture to 5.500% Senior Notes Due 2027 between HZNP Finance Limited and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2020
Description of Share Capital of Horizon Therapeutics plc
Stock Agreements
Horizon Pharma plc
Pharmaceuticals
2020
Release and Waiver of Claims Agreement between Robert F. Carey and Horizon Therapeutics PLC
Release Agreements
Horizon Pharma plc
Pharmaceuticals
2019
Indenture for 5.500% Senior Notes Due 2027 between Horizon Pharma USA, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2019
Horizon Therapeutics plc 2014 Non-Employee Equity Plan
Equity Distribution Agreements
Horizon Pharma plc
Pharmaceuticals
CA
2019
Horizon Therapeutics Amended and Restated 2014 Equity Incentive Plan
Equity Distribution Agreements
Horizon Pharma plc
Pharmaceuticals
CA
2019
Underwriting Agreement between Horizon Pharma Public Limited Company and Underwriters (Citigroup, Morgan Stanley, Goldman Sachs, Cowen) dated March 6, 2019
Underwriting Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2019
Seventh Supplemental Indenture to 6.625% Senior Notes Due 2023—Horizon Medicines LLC, Horizon Pharma USA, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2019
Third Supplemental Indenture to 8.750% Senior Notes Due 2024—Horizon Medicines LLC and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2019
Sixth Supplemental Indenture to 6.625% Senior Notes Due 2023 between Horizon Pharma USA, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Fifth Supplemental Indenture to 6.625% Senior Notes Due 2023—Horizon Pharma Services LLC, Horizon Pharma, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Fourth Supplemental Indenture to 6.625% Senior Notes Due 2023—Horizon Pharma Tepro, Inc., Horizon Pharma, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Third Supplemental Indenture to 6.625% Senior Notes Due 2023—Raptor Pharmaceutical Corp., Raptor Pharmaceuticals Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Second Supplemental Indenture to 6.625% Senior Notes Due 2023—Horizon Pharma Rheumatology LLC, Horizon Pharma, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Second Supplemental Indenture among Horizon Pharma Services LLC, Horizon Pharma, Inc., and U.S. Bank National Association (Trustee)
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
First Supplemental Indenture to 8.750% Senior Notes Due 2024—Horizon Pharma Tepro, Inc., Horizon Pharma, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Letter Agreement Modifying Payment Terms for 2017 API Purchase under Manufacturing and Supply Agreement between Sanofi US Services Inc. and Horizon Pharma USA, Inc.
Modification Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Horizon Pharma plc 2014 Equity Incentive Plan (as Amended)
Equity Distribution Agreements
Horizon Pharma plc
Pharmaceuticals
CA
2018
Amendment to Manufacturing and Supply Agreement between Jagotec AG and Horizon Pharma Ireland Limited
Modification Agreements
Horizon Pharma plc
Pharmaceuticals
2017
Indenture for 8.750% Senior Notes Due 2024 between Horizon Pharma, Inc., Horizon Pharma USA, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2016
Horizon Pharma plc and Goodbody Trustees Limited Director Share Clog Program Trust Deed (2015)
Trust Agreements
Horizon Pharma plc
Pharmaceuticals
2016
Horizon Pharma plc and Goodbody Trustees Limited Director Share Clog Program Trust Deed (2015)
Trust Agreements
Horizon Pharma plc
Pharmaceuticals
2015
First Supplemental Indenture among Horizon Pharma, Inc., Guarantors, and U.S. Bank National Association (May 7, 2015)
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2015
Credit Agreement among Horizon Pharma, Inc., Horizon Pharma Public Limited Company, Subsidiary Guarantors, Lenders, and Citibank, N.A. (May 7, 2015)
Credit Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2015
Indenture for 6.625% Senior Notes Due 2023 between Horizon Pharma Financing Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2015
Underwriting Agreement between Horizon Pharma Public Limited Company and Underwriters for Sale of Ordinary Shares
Underwriting Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2015
Indenture for 2.50% Exchangeable Senior Notes due 2022 among Horizon Pharma Investment Limited, Horizon Pharma Public Limited Company, and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2015
Assignment and Option Agreement between InterMune Pharmaceuticals, Inc. and Connetics Corporation (June 23, 2000)
Assignment Agreements
Horizon Pharma plc
Pharmaceuticals
CA
2015
Consent to Assignment Agreement among Genentech, Connetics, and InterMune Pharmaceuticals (June 23, 2000)
Assignment Agreements
Horizon Pharma plc
Pharmaceuticals
2015